Jaguar Health in red after ramp-up in 2022 Mytesi revenue misses estimates by Technical Terrence Team 03/27/2023 0 Jaguar Health (NASDAQ:JAGX) shares fell -9% on Monday after the drug company missed revenue estimates despite a 176% year-over-year jump ...
Prometheus-Eval and Prometheus 2: Setting new standards in LLM assessment and open source innovation with a next-generation assessment language model 05/22/2024